日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity

针对A型血友病的I期试点研究:AAV8载体联合预防性他克莫司-糖皮质激素治疗可达到治疗性FVIII活性。

Liu, Wei; Pei, Xiaolei; Yu, Tenghui; Xu, Bingqi; Dai, Xinyue; Xue, Feng; Chen, Lingling; Wang, Xiaolin; Wang, Yuhua; Chen, Yunfei; Liu, Xiaofan; Fu, Rongfeng; Wang, Wentian; Chi, Ying; Li, Hui Yuan; Yang, Renchi; Zhang, Lei

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

PRIME-HFrEF试验:一项针对心力衰竭的随机、双盲、多剂量脐带间充质干细胞治疗方案

Han, Wei; Jiao, Yuheng; Chen, Wei; Gong, Xin; Hu, Hao; Xin, Yuanfeng; Guan, Sibin; Zhao, Jun; Zhang, Qi; Yang, Bing; Pan, Jingwei; Wang, Haiyan; Lu, Qing; Chu, Shuguang; Cai, Dihui; Zheng, Liang; Jia, Wenwen; He, Zhiying; Yang, Huangtian; Sun, Yi Eve; Liu, Zhongmin

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications

活性氧(ROS)在癌症中的作用:从机制到治疗意义

Akter, Sharmin; Madhuvilakku, Rajesh; Kar, Anik Kumar; Nila, Irin Sultana; Liu, Pengda; Inuzuka, Hiroyuki; Wei, Wenyi; Hong, Yonggeun

Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial

一项随机、双盲、安慰剂对照的2b期临床试验,旨在评估GLP-1受体激动剂波方鲁肽在中国超重或肥胖成年人中的疗效和安全性。

Ji, Linong; Gao, Leili; Tian, Junhang; Dong, Ruihua; Zhang, Zhongtao; Shu, Hongyan; Zhao, Jing; Zhao, Liyuan; He, Anshun; Xie, Tian; Li, Yue; Chen, Wei

Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy

内质网应激在疾病发病机制中的作用:其对治疗的意义

Wei, Siyu; Zhang, Nan; Zhang, Hao; Chen, Zigui; Li, Shuyu; Wu, Wantao; Liu, Zaoqu; Xia, Zhiwei; Luo, Peng; Cheng, Quan

Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.

利用针对膜近端 AXL 的抗体对肿瘤微环境进行重编程,以克服免疫检查点阻断耐药性。

Yang Zuming, Cao Shuaishuai, Zhang Jiaen, Nie Xiaohua, Wang Zhimin, Yang Shaojun, Wang Jingshu, Sun Xin, Kuang Xueli, Huang Huiming, Wei Zifan, Duan Pengfei, Tang Mingwan, Zhang Liyu, Ren Zhenhua, Lan Xun, Fu Yang-Xin, Zhang Liguo, Zhang Xuyuan, Liang Yong

MAPK14 converges on key transcriptional machinery to promote vascular smooth muscle cell degeneration in abdominal aortic aneurysm.

MAPK14 作用于关键转录机制,促进腹主动脉瘤血管平滑肌细胞退化。

Wu Xiaoliang, Wang Chunhui, Ishimwe Nestor, Zhang Wei, Doja Jaser, Shan Shengshuai, Ge Chunyu, Sun Yong, Zhao Jinjing, Castillo Micah, Sotonyi Peter, Gyurok Gergo, Csanyi Gabor, Bryant W Bart, Dong Kunzhe, Chen Yabing, Vazquez-Padron Roberto, Miano Joseph M, Long Xiaochun

Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials

IX因子-Padua AAV基因疗法治疗B型血友病:1/2期和3期试验

Xue, Feng; Ju, Mankai; Zhu, Tienan; Zhou, Zeping; Sun, Jing; Yang, Linhua; Yan, Zhenyu; Zhou, Hu; Du, Xin; Zheng, ChangCheng; Zheng, Jing; Wu, Xia; Du, Zengmin; Jiang, Wei; Yang, Caifeng; Xiao, Xiao; Liu, Wei; Yang, Renchi; Zhang, Lei